Cambridge Investment Research Advisors’s Steris STE Stock Holding History
Bought
Maintained
Sold
Other funds holding STE
OAG
GIM
Cambridge Investment Research Advisors's STE Position: Q2 2026 in Review
Cambridge Investment Research Advisors reduced its Steris (STE) stake by 26% in Q2 2026, selling an estimated $612K and leaving 7,965 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1826.
Cambridge Investment Research Advisors first reported a position in STE in Q3 2019 and has held it in 27 quarters since. The position peaked at $2.73M in Q4 2025. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.
- Cambridge Investment Research Advisors held 7,965 shares of Steris worth $1.68M as of Q2 2026.
- Cambridge Investment Research Advisors sold 2,855 Steris shares in Q2 2026, an estimated $612K.
- Steris made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1826 holding.
- Cambridge Investment Research Advisors first reported a position in Steris in Q3 2019 and has held it in 27 quarters since.
- Cambridge Investment Research Advisors's Steris position peaked at $2.73M in Q4 2025.
- 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.